Charles Wesley’s Role in the Formative Early Years in Bristol, 1739‐41
The Journal of Religious History, Literature and Culture · 2024
DOI: 10.16922/jrhlc.10.2.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Religious History, Literature and Culture, 2024. Verfasst von Gary M. Best. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
This essay situates Charles Wesley primarily as an evangelist and church leader and illuminates his central role in this turbulent and formative period of Methodism’s history. From late 1739 Charles began to preach in Bristol and the surrounding area, following the initiatives launched first by George Whitefield and then by John Wesley. He offered his hearers a straightforward path to salvation, and often attracted large and enthusiastic crowds. However, his efforts also drew significant and sometimes violent opposition, and there was also tension between Charles and Whitefield and another active preacher, the layman John Cennick, partly because of the Wesleys’ aversion to Whitefield’s Calvinism, and partly because of John Wesley’s distinctive doctrine of Christian perfection. By January 1741 these problems were seriously undermining the overall evangelistic campaign in Bristol, leading to a split within the movement. Charles, however, sought to continue the brothers’ joint enterprise with the Calvinists and took a conciliatory approach.
Zitieren
APA
Best, G. M. (2024). Charles Wesley’s Role in the Formative Early Years in Bristol, 1739‐41. The Journal of Religious History, Literature and Culture. https://doi.org/10.16922/jrhlc.10.2.2
Vancouver
Best GM. Charles Wesley’s Role in the Formative Early Years in Bristol, 1739‐41. The Journal of Religious History, Literature and Culture. 2024. doi:10.16922/jrhlc.10.2.2
BibTeX
@article{Best2024,
author = {Best, Gary M.},
title = {Charles Wesley’s Role in the Formative Early Years in Bristol, 1739‐41},
journal = {The Journal of Religious History, Literature and Culture},
year = {2024},
doi = {10.16922/jrhlc.10.2.2}
}
EUVIMED